BRANDI CLOKEY: Open Payments
NPI 1396398491 · DENTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$881 in 44 payments from 15 companies in 2025. Trend: 2023 $749 · 2024 $578 · 2025 $881
Food & beverage: $881
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $179 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $147 |
| Lundbeck LLC | 8 | $145 |
| Teva Pharmaceuticals USA, Inc. | 4 | $84 |
| AstraZeneca Pharmaceuticals LP | 4 | $76 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Viatris Specialty LLC | 1 | $40 |
| Lilly USA, LLC | 2 | $38 |
| Paratek Pharmaceuticals, Inc. | 1 | $29 |
| Mannkind Corporation | 1 | $20 |
Products named: REXULTI, CAPLYTA, QULIPTA, AUSTEDO XR, VRAYLAR, AIRSUPRA, YUPELRI, KISUNLA.
Industry payments across TX — which companies pay providers there.
